MA H1121 | 2021-2022 | 192nd General Court

Note: Legislation replaced by H4975

Status

Spectrum: Partisan Bill (Republican 7-0)
Status: Introduced on March 29 2021 - 25% progression, died in chamber
Action: 2022-09-01 - Accompanied a study order, see H4975
Text: Latest bill text (Introduced) [PDF]

Summary

Relative to maximum allowable costs lists utilized by payers and pharmaceutical benefit managers to identify the maximum amount health plans will pay for certain prescription drugs. Financial Services.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Establishing a commission to study maximum allowable costs lists

Sponsors


History

DateChamberAction
2022-09-01HouseAccompanied a study order, see H4975
2021-09-14JointHearing scheduled for 09/21/2021 from 10:00 AM-03:00 PM in Virtual Hearing
2021-03-29SenateSenate concurred
2021-03-29HouseReferred to the Joint Committee on Financial Services

Same As/Similar To

S636 (Similar To) 2022-06-09 - Accompanied a study order, see S2917
S714 (Similar To) 2022-02-17 - Accompanied a study order, see S2701
H1143 (Similar To) 2022-09-01 - Accompanied a study order, see H4975
H1192 (Similar To) 2022-09-15 - Accompanied a study order, see H5222
S816 (Similar To) 2022-03-31 - Accompanied a study order, see S2800
S732 (Similar To) 2022-06-09 - Accompanied a study order, see S2917
H4975 (Replaced by) 2023-01-03 - No further action taken

Massachusetts State Sources


Bill Comments

feedback